title: The future of smoking cessation therapy in the United States.
abstract: Six trends that are likely to influence the future content, format, delivery and reach of smoking cessation therapy in the United States are discussed: (1) changing characteristics of smokers (e.g. more likely to be poor, have psychiatric co-morbidity and be more nicotine dependent), (2) health care reform demands for cost-effectiveness, (3) development of guidelines/algorithms that recommend stepped-care approaches, (4) continued emphasis on smoking as a form of drug dependence requiring intensive pharmacological and behavior therapy for some smokers, (5) interest in harm-reduction strategies for smokers unable or unwilling to quit (and 6) smoking cessation therapies become reimbursable on par with other drug dependencies.
authors.affiliation: Human Behavioral Pharmacology Laboratory, University of Vermont, USA. john.hughes@uvm.edu
authors.forename: J R
authors.initials: JR
authors.lastname: Hughes
mesh_terms: D003131:Combined Modality Therapy; D015897:Comorbidity; D003362:Cost-Benefit Analysis; D005544:Forecasting; D006801:Humans; D012907:Smoking / Q000453:epidemiology / Q000523:psychology; D016540:Smoking Cessation / Q000191:economics / Q000379:methods*; D000074606:Smoking Prevention; D019966:Substance-Related Disorders / Q000523:psychology / Q000534:rehabilitation; D014481:United States